IGIV-C, a novel intravenous immunoglobulin: Evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.
Thrombosis and Haemostasis.
Times cited: 47
Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura.
Journal of Pediatric Hematology/Oncology.
Times cited: 44
Diagnosis and treatment of idiopathic thrombocytopenic purpura: Recommendations of the American Society of Hematology.
Annals of Internal Medicine.
Times cited: 122